News
HeartFlow recently filed a Form S-1 with the SEC to confirm its intent to complete an initial public offering (IPO) and go ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
The former Emperor of Japan has been admitted to a hospital in Tokyo to undergo treatment for a heart condition, the Imperial ...
This marks the second FDA-cleared ECG-AI device in Tempus’ cardiovascular product suite, following its previously cleared Tempus ECG-AF solution. The new software analyzes resting, non-ambulatory ...
5d
InvestorsHub on MSNTempus AI shares climb after FDA approval of heart monitoring softwareTempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) ...
The global ECG Sensor Patches Market, valued at US$0.95 billion in 2024 stood at US$1.05 billion in 2025 and is projected to advance at a resilient CAGR of 12.0% from 2025 to 2032, culminating in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results